Organon (OGN) Tops Q4 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Organon (OGN) Tops Q4 EPS by 10c

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021

February 17, 2022 6:30 AM EST

Nexplanon® (etonogestrel implant), fertility, biosimilars grew double digits for full year

Full year 2021 revenue of $6.3 billion Income from continuing operations before tax of $1.5 billion for full year 2021 Full year Adjusted EBITDA of $2.4 billion Company executing on business development; four transactions since spin Full year 2022 financial guidance provided; revenue range of $6.1 billion to $6.4 billion and Adjusted EBITDA margins in the range of 34%-36%

JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) today announced its... More